Long-read sequencing is a DNA sequencing approach that enables the sequencing of much longer DNA fragments than traditional short-read sequencing methods. While short reads can capture the majority of genetic variation, long-read sequencing allows the detection of complex structural variants in the genome that may be difficult to detect with short reads. These include large inversions, deletions, or translocations, some of which have been implicated in genetic disease.
Long-read sequencing technology can help resolve challenging regions of the genome by sequencing thousands of bases to:

We have a broad range of innovations in development, including constellation mapped read technology, which uses a highly simplified NGS workflow that enables on-flow cell library prep and standard short-reads with cluster proximity information.
View innovation roadmapIllumina mapped read technology provides long-distance genomic information that can help scientists detect large structural variants and resolve challenging-to-map regions. While technically a short-read technology, Illumina mapped reads leverage on-flow cell library preparation and novel informatics that incorporate proximity information from clusters in neighboring nanowells to generate accurate long-range genomic insights. The unique workflow maintains the link between the original long DNA template and the resulting short sequencing reads, enabling enhanced detection of structural variants, ultra-long phasing of genetic variants, and improved mapping in low-complexity regions.

DNA templates are extracted from samples using standard or high molecular weight methods and introduced directly to the flow cell surface, where they are captured, transformed into clusters, and sequenced. By introducing long DNA templates directly to the flow cell, proximal nanowells produce a constellation-like pattern that allows clusters to be mapped back to the original template using novel algorithms in DRAGEN secondary analysis. This significantly improves mapping reads to a reference genome and allows scientists to unlock long-range genomic insights with the accuracy and scalability of short-read SBS sequencing.
Long-read sequencing technology has the potential to improve the efficiency and accuracy of some existing DNA sequencing applications while increasing the resolution of some clinically important genes.
These advantages allow for the phased re‐sequencing of human genomes and rapid de novo sequencing of plant and animal genomes.
The long reads produced typically span more than one heterozygous SNP in the phasing application. The technology simplifies de novo sequencing because large repeat regions in the DNA fragments can easily be spanned.
The long reads produced typically span more than one heterozygous SNP, which can facilitate mapping them to the correct maternal or paternal chromosome during phasing applications.
Long reads can also span large repetitive motifs which simplifies mapping in challenging sequences and de novo sequencing.
Transposase enzyme-linked long-read sequencing (TELL-Seq) technology uses linked reads to generate non-contiguous, long-range data to inform de novo assembly or ultra-long distance (> 1 Mb) phasing. This alternative sequencing data type can be used to complement standard short reads for novel or complex genomes.
TELL-Seq technology generates ultra-long phasing blocks, providing an accessible solution to perform genome phasing studies.
TELL-Seq demonstrates exceptional performance for microbial WGS, even for challenging samples or regions with high GC content.
Learn how researchers use transposase enzyme-linked long-read sequencing (TELL-Seq) to sequence and assemble genomes of nine insect species in this recorded webinar.
Whole-genome sequencing is the most comprehensive test for rare disease, with the potential for superior diagnostics and outcomes.
Human whole-genome sequencing provides the most detailed view into the complex genetic variants that make us unique.
Get a comprehensive base-by-base view of the unique genomic abnormalities in cancer.
Compare next-generation sequencing (NGS) platforms by application, throughput, and other key specs. Find tools to help you choose the right sequencer.
Read articles about recent genomics breakthroughs and advances in bioinformatics and clinical research from Illumina scientists and thought leaders.
During DNA sequencing, the bases of a fragment of DNA are identified. Illumina DNA sequencers can produce terabases of sequence data from a single run.